Nuclear Medicine: Radioactivity for diagnosis and therapy
Nuclear medicine is a specialized medical field based on the application of radiopharmaceuticals, i.e. drugs associated to radioactivity, for diagnosis or therapeutic purposes. In the past fifty years, nuclear medicine has progressed in such a way that it is now a major tool in hospitals. Nowadays,...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Les Ulis
EDP Sciences
[2007]
|
| Schriftenreihe: | Hors collection
|
| Schlagworte: | |
| Online-Zugang: | DE-Aug4 Volltext |
| Zusammenfassung: | Nuclear medicine is a specialized medical field based on the application of radiopharmaceuticals, i.e. drugs associated to radioactivity, for diagnosis or therapeutic purposes. In the past fifty years, nuclear medicine has progressed in such a way that it is now a major tool in hospitals. Nowadays, this technology enables to better detect, observe and describe diseases, and also to improve treatments. Cancer therapy is the main application of this speciality. Once injected to the patient, the radiopharmaceutical drug aims selectively at the tumoral cells, including the metastases, settles there and emits radiation. Depending on the type of radiation, the drug will either help to identify the cells or to destroy them. Recent breakthroughs in this technology bring new perspectives to oncology, haematology and neurology. At the same time, since the beginning of the 21st century nuclear medicine has also benefited from a double revolution in terms of imaging technology. On the one hand, the Positron Emission Tomography (PET) made a real impact with a polyvalent imaging drug called FDG. On the other hand, a new tool combining functional and morphological imaging (PET-CT) was very recently made available to the medical community. This scientific book aims to introduce nuclear medicine to a larger audience, pointing out, among other things, the difficulties both physicians and patients meet when trying to access new technologies. There are still some issues to overcome, but recent scientific breakthroughs bring great hopes for patients in the near future |
| Beschreibung: | Description based on online resource; title from PDF title page (publisher's Web site, viewed 30. Aug 2022) |
| Beschreibung: | 1 Online-Ressource (184 pages) |
| ISBN: | 9782759802555 |
| DOI: | 10.1051/978-2-7598-0255-5 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV048457444 | ||
| 003 | DE-604 | ||
| 005 | 20241203 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 220906s2007 xx o|||| 00||| eng d | ||
| 020 | |a 9782759802555 |9 978-2-7598-0255-5 | ||
| 024 | 7 | |a 10.1051/978-2-7598-0255-5 |2 doi | |
| 035 | |a (ZDB-23-DGG)9782759802555 | ||
| 035 | |a (OCoLC)1344251868 | ||
| 035 | |a (DE-599)BVBBV048457444 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-Aug4 | ||
| 082 | 0 | |a 616.07575 | |
| 100 | 1 | |a Zimmermann, Richard |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Nuclear Medicine |b Radioactivity for diagnosis and therapy |c Richard Zimmermann |
| 264 | 1 | |a Les Ulis |b EDP Sciences |c [2007] | |
| 264 | 4 | |c © 2007 | |
| 300 | |a 1 Online-Ressource (184 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Hors collection | |
| 500 | |a Description based on online resource; title from PDF title page (publisher's Web site, viewed 30. Aug 2022) | ||
| 520 | |a Nuclear medicine is a specialized medical field based on the application of radiopharmaceuticals, i.e. drugs associated to radioactivity, for diagnosis or therapeutic purposes. In the past fifty years, nuclear medicine has progressed in such a way that it is now a major tool in hospitals. Nowadays, this technology enables to better detect, observe and describe diseases, and also to improve treatments. Cancer therapy is the main application of this speciality. Once injected to the patient, the radiopharmaceutical drug aims selectively at the tumoral cells, including the metastases, settles there and emits radiation. Depending on the type of radiation, the drug will either help to identify the cells or to destroy them. Recent breakthroughs in this technology bring new perspectives to oncology, haematology and neurology. At the same time, since the beginning of the 21st century nuclear medicine has also benefited from a double revolution in terms of imaging technology. On the one hand, the Positron Emission Tomography (PET) made a real impact with a polyvalent imaging drug called FDG. On the other hand, a new tool combining functional and morphological imaging (PET-CT) was very recently made available to the medical community. This scientific book aims to introduce nuclear medicine to a larger audience, pointing out, among other things, the difficulties both physicians and patients meet when trying to access new technologies. There are still some issues to overcome, but recent scientific breakthroughs bring great hopes for patients in the near future | ||
| 546 | |a In English | ||
| 650 | 7 | |a MEDICAL / Laboratory Medicine |2 bisacsh | |
| 856 | 4 | 0 | |u https://doi.org/10.1051/978-2-7598-0255-5 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-23-DGG | ||
| 940 | 1 | |q FHA_PDA_EMB | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-033835496 | |
| 966 | e | |u https://doi.org/10.1051/978-2-7598-0255-5 |l DE-Aug4 |p ZDB-23-DGG |q FHA_PDA_DGG |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1817409165092454400 |
|---|---|
| adam_text | |
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Zimmermann, Richard |
| author_facet | Zimmermann, Richard |
| author_role | aut |
| author_sort | Zimmermann, Richard |
| author_variant | r z rz |
| building | Verbundindex |
| bvnumber | BV048457444 |
| collection | ZDB-23-DGG |
| ctrlnum | (ZDB-23-DGG)9782759802555 (OCoLC)1344251868 (DE-599)BVBBV048457444 |
| dewey-full | 616.07575 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.07575 |
| dewey-search | 616.07575 |
| dewey-sort | 3616.07575 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| doi_str_mv | 10.1051/978-2-7598-0255-5 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zc 4500</leader><controlfield tag="001">BV048457444</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20241203</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">220906s2007 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9782759802555</subfield><subfield code="9">978-2-7598-0255-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1051/978-2-7598-0255-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-23-DGG)9782759802555</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1344251868</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048457444</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-Aug4</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.07575</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zimmermann, Richard</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nuclear Medicine</subfield><subfield code="b">Radioactivity for diagnosis and therapy</subfield><subfield code="c">Richard Zimmermann</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Les Ulis</subfield><subfield code="b">EDP Sciences</subfield><subfield code="c">[2007]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2007</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (184 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Hors collection</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on online resource; title from PDF title page (publisher's Web site, viewed 30. Aug 2022)</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Nuclear medicine is a specialized medical field based on the application of radiopharmaceuticals, i.e. drugs associated to radioactivity, for diagnosis or therapeutic purposes. In the past fifty years, nuclear medicine has progressed in such a way that it is now a major tool in hospitals. Nowadays, this technology enables to better detect, observe and describe diseases, and also to improve treatments. Cancer therapy is the main application of this speciality. Once injected to the patient, the radiopharmaceutical drug aims selectively at the tumoral cells, including the metastases, settles there and emits radiation. Depending on the type of radiation, the drug will either help to identify the cells or to destroy them. Recent breakthroughs in this technology bring new perspectives to oncology, haematology and neurology. At the same time, since the beginning of the 21st century nuclear medicine has also benefited from a double revolution in terms of imaging technology. On the one hand, the Positron Emission Tomography (PET) made a real impact with a polyvalent imaging drug called FDG. On the other hand, a new tool combining functional and morphological imaging (PET-CT) was very recently made available to the medical community. This scientific book aims to introduce nuclear medicine to a larger audience, pointing out, among other things, the difficulties both physicians and patients meet when trying to access new technologies. There are still some issues to overcome, but recent scientific breakthroughs bring great hopes for patients in the near future</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">In English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Laboratory Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1051/978-2-7598-0255-5</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-23-DGG</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FHA_PDA_EMB</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033835496</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1051/978-2-7598-0255-5</subfield><subfield code="l">DE-Aug4</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">FHA_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV048457444 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T20:32:36Z |
| indexdate | 2024-12-03T09:00:43Z |
| institution | BVB |
| isbn | 9782759802555 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033835496 |
| oclc_num | 1344251868 |
| open_access_boolean | |
| owner | DE-Aug4 |
| owner_facet | DE-Aug4 |
| physical | 1 Online-Ressource (184 pages) |
| psigel | ZDB-23-DGG FHA_PDA_EMB ZDB-23-DGG FHA_PDA_DGG |
| publishDate | 2007 |
| publishDateSearch | 2007 |
| publishDateSort | 2007 |
| publisher | EDP Sciences |
| record_format | marc |
| series2 | Hors collection |
| spelling | Zimmermann, Richard Verfasser aut Nuclear Medicine Radioactivity for diagnosis and therapy Richard Zimmermann Les Ulis EDP Sciences [2007] © 2007 1 Online-Ressource (184 pages) txt rdacontent c rdamedia cr rdacarrier Hors collection Description based on online resource; title from PDF title page (publisher's Web site, viewed 30. Aug 2022) Nuclear medicine is a specialized medical field based on the application of radiopharmaceuticals, i.e. drugs associated to radioactivity, for diagnosis or therapeutic purposes. In the past fifty years, nuclear medicine has progressed in such a way that it is now a major tool in hospitals. Nowadays, this technology enables to better detect, observe and describe diseases, and also to improve treatments. Cancer therapy is the main application of this speciality. Once injected to the patient, the radiopharmaceutical drug aims selectively at the tumoral cells, including the metastases, settles there and emits radiation. Depending on the type of radiation, the drug will either help to identify the cells or to destroy them. Recent breakthroughs in this technology bring new perspectives to oncology, haematology and neurology. At the same time, since the beginning of the 21st century nuclear medicine has also benefited from a double revolution in terms of imaging technology. On the one hand, the Positron Emission Tomography (PET) made a real impact with a polyvalent imaging drug called FDG. On the other hand, a new tool combining functional and morphological imaging (PET-CT) was very recently made available to the medical community. This scientific book aims to introduce nuclear medicine to a larger audience, pointing out, among other things, the difficulties both physicians and patients meet when trying to access new technologies. There are still some issues to overcome, but recent scientific breakthroughs bring great hopes for patients in the near future In English MEDICAL / Laboratory Medicine bisacsh https://doi.org/10.1051/978-2-7598-0255-5 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Zimmermann, Richard Nuclear Medicine Radioactivity for diagnosis and therapy MEDICAL / Laboratory Medicine bisacsh |
| title | Nuclear Medicine Radioactivity for diagnosis and therapy |
| title_auth | Nuclear Medicine Radioactivity for diagnosis and therapy |
| title_exact_search | Nuclear Medicine Radioactivity for diagnosis and therapy |
| title_exact_search_txtP | Nuclear Medicine Radioactivity for diagnosis and therapy |
| title_full | Nuclear Medicine Radioactivity for diagnosis and therapy Richard Zimmermann |
| title_fullStr | Nuclear Medicine Radioactivity for diagnosis and therapy Richard Zimmermann |
| title_full_unstemmed | Nuclear Medicine Radioactivity for diagnosis and therapy Richard Zimmermann |
| title_short | Nuclear Medicine |
| title_sort | nuclear medicine radioactivity for diagnosis and therapy |
| title_sub | Radioactivity for diagnosis and therapy |
| topic | MEDICAL / Laboratory Medicine bisacsh |
| topic_facet | MEDICAL / Laboratory Medicine |
| url | https://doi.org/10.1051/978-2-7598-0255-5 |
| work_keys_str_mv | AT zimmermannrichard nuclearmedicineradioactivityfordiagnosisandtherapy |